Quercetin prevents bone loss in hindlimb suspension mice via stanniocalcin 1-mediated inhibition of osteoclastogenesis.

Published on Sep 15, 2020in Acta Pharmacologica Sinica5.064
· DOI :10.1038/S41401-020-00509-Z
Yinbo Niu13
Estimated H-index: 13
(NPU: Northwestern Polytechnical University),
Yuan-Yuan Yang1
Estimated H-index: 1
(NPU: Northwestern Polytechnical University)
+ 8 AuthorsQibing Mei32
Estimated H-index: 32
(NPU: Northwestern Polytechnical University)
Recent studies demonstrate that diet quercetin (Quer) has obvious bone protective effects on ovariectomized rodents but thus far there is no direct evidence to support the inhibitory effect of Quer on bone loss caused by long-term unloading. In the present study, we investigated whether Quer could prevent bone loss induced by unloading in mice. Mice were subjected to hindlimb suspension (HLS) and received Quer (25, 50, 100 mg· kg-1 ·day-1, ig) for 4 weeks. Before euthanasia blood sample was collected; the femurs were harvested and subjected to MicroCT analysis. We showed that Quer administration markedly improved bone microstructure evidenced by dose-dependently reversing the reduction in bone volume per tissue volume, trabecular number, and bone mineral density, and the increase of trabecular spacing in mice with HLS. Analysis of serum markers and bone histometric parameters confirmed that Quer at both middle and high doses significantly decreased bone resorption-related markers collagen type I and tartrate-resistant acid phosphatase 5b, and increased bone formation-related marker procollagen 1 N-terminal propeptide as compared with HLS group. Treatment with Quer (1, 2, 5 μM) dose-dependently inhibited RANKL-induced osteoclastogenesis through promoting the expression of antioxidant hormone stanniocalcin 1 (STC1) and decreasing ROS generation; knockdown of STC1 blocked the inhibitory effect of Quer on ROS generation. Knockdown of STC1 also significantly promoted osteoclastogenesis in primary osteoclasts. In conclusion, Quer protects bones and prevents unloading-caused bone loss in mice through STC1-mediated inhibition of osteoclastogenesis. The findings suggest that Quer has the potential to prevent and treat off-load bone loss as an alternative supplement.
📖 Papers frequently viewed together
1 Citations
180 Citations
1 Citations
#1Feng Shen (SCUT: South China University of Technology)H-Index: 4
#2Haoquan Zhong (SCUT: South China University of Technology)H-Index: 5
Last. Xiaohui Wang (SCUT: South China University of Technology)H-Index: 32
view all 5 authors...
Abstract Natural active compounds with antioxidant properties and other potential health benefits, like quercetin (Qu), have aroused wide concern for developing bio-functional products. However, their applications are hindered by their intrinsic poor water solubility and chemical instability. In this paper, a natural antioxidant alpha lipoic acid (ALA) was grafted onto chitosan (CS) to synthesize a novel graft polymer (CS-graft-ALA). In particular, this graft-polymer could self-assemble into sph...
6 CitationsSource
#1Alex DeLong (PSU: Pennsylvania State University)H-Index: 1
#2Michael A Friedman (VCU: Virginia Commonwealth University)H-Index: 3
Last. Gregory S. Lewis (PSU: Pennsylvania State University)H-Index: 18
view all 7 authors...
Prolonged reduction in weightbearing causes bone loss. Disuse of bone is associated with recovery from common musculoskeletal injury and trauma, bed rest resulting from various medical conditions, and spaceflight. The hindlimb-suspension rodent model is popular for simulating unloading and disuse. We hypothesized that controlled mechanical loading of the tibia would protect against bone loss occurring from concurrent disuse. Additionally, we hypothesized that areas of high mechanical peak strain...
3 CitationsSource
#1Qiaowen Ou (Guangdong Pharmaceutical University)H-Index: 1
#2Zhifen ZhengH-Index: 1
Last. Weiqun Lin (Guangdong Pharmaceutical University)H-Index: 1
view all 4 authors...
AbstractKnowledge regarding the anti-inflammatory capability of quercetin remains inconclusive and controversial due to the heterogeneous methods and inconsistent results of RCTs. We performed a series of meta-analyses of RCTs to evaluate the impact of quercetin supplementation on inflammatory biomarkers. Three cytokines (CRP, IL-6, TNF-α) with enough eligible studies (n = 6, 5 and 4, respectively) were selected for further meta-analyses. Data from these RCTs were pooled, and both overall effect...
9 CitationsSource
#1Mohammed S. AlQranei (UMB: University of Maryland, Baltimore)H-Index: 1
#2Hanan Aljohani (KSU: King Saud University)H-Index: 5
Last. Meenakshi A. Chellaiah (UMB: University of Maryland, Baltimore)H-Index: 31
view all 5 authors...
Excessive bone loss occurs in inflammatory disorders such as periodontitis and osteoporosis. The underlying mechanism is related to the differentiation of macrophages into multinucleated giant osteoclasts and their bone resorptive activity. C-Phycocyanin (C-PC) is a phycobiliprotein extracted from the blue-green algae, which has been shown to have various pharmacological effects. The role of C-PC on bone metabolism needs revelation. In this study, we determined the effectiveness of C-PC as an in...
5 CitationsSource
#1Zhen Yuan (NCU: Nanchang University)H-Index: 3
#2Jun Min (NCU: Nanchang University)H-Index: 2
Last. Hao Liu (NCU: Nanchang University)H-Index: 1
view all 8 authors...
To investigate the effect of quercetin on promoting the proliferation of bone marrow mesenchymal stem cells (BMSCs) and improving osteoporosis in rats. Rats were randomly divided into the sham, OVX and quercetin+OVX groups. In the sham and OVX groups, rats were given carboxymethyl cellulose sodium (CMC-Na). In the quercetin+OVX group, rats were given quercetin (50 mg/kg) once a day. Eight weeks after rats were treated, femurs were subjected to micro-CT scans, and bone biomechanical properties we...
20 Citations
#1Andrea V. Haas (Brigham and Women's Hospital)H-Index: 5
#2Meryl S. LeBoff (Brigham and Women's Hospital)H-Index: 62
: Medications for osteoporosis are classified as either antiresorptive or anabolic. Whereas antiresorptive agents prevent bone resorption, anabolic agents promote new bone formation. Anabolics should be considered in individuals with severe osteoporosis, failure of alternative osteoporosis agents, intolerability or contraindications to other osteoporosis agents, and glucocorticoid-induced osteoporosis. There are currently two approved anabolic therapies, teriparatide and abaloparatide, and a thi...
27 CitationsSource
#1Andrea M. Brum (EUR: Erasmus University Rotterdam)H-Index: 3
#2Jeroen van de Peppel (EUR: Erasmus University Rotterdam)H-Index: 18
Last. B.C.J. van der Eerden (EUR: Erasmus University Rotterdam)H-Index: 8
view all 11 authors...
Osteoporosis is a common skeletal disorder characterized by low bone mass leading to increased bone fragility and fracture susceptibility. Identification of factors influencing osteoblast differentiation and bone formation is very important. Previously, we identified parbendazole to be a novel compound that stimulates osteogenic differentiation of human mesenchymal stromal cells (hMSCs), using gene expression profiling and bioinformatic analyzes, including the Connectivity Map (CMap), as an in-s...
9 CitationsSource
5 CitationsSource
#1Emily A. Southmayd (PSU: Pennsylvania State University)H-Index: 7
#2Adelaide C. Hellmers (PSU: Pennsylvania State University)H-Index: 1
Last. Mary Jane De Souza (PSU: Pennsylvania State University)H-Index: 42
view all 3 authors...
Purpose of Review The review aims to summarize our current knowledge surrounding treatment strategies aimed at recovery of bone mass in energy-deficient women suffering from the Female Athlete Triad.
9 CitationsSource
#1Tao Wang (Guangxi Medical University)H-Index: 6
#2Qian Liu (Guangxi Medical University)H-Index: 14
Last. Haotian Feng (Guangxi Medical University)H-Index: 15
view all 10 authors...
Osteoporosis, a bone disease resulting in the loss of bone density and microstructure quality, is often associated with fragility fractures, and the latter imposes a great burden on the patient and society. Although there are several different treatments available for osteoporosis such as hormone replacement therapy, bisphosphonates, Denosumab, and parathyroid hormone, some concerns have been raised regarding the inherent side effects of their long term use. It would be of great relevance to sea...
33 CitationsSource
Cited By1
Natural products, especially phenols, are promising therapeutic agents with beneficial effects against aging-related complications such as osteoporosis. This study aimed to investigate the effect of quercetin 3-O-β-D-galactopyranoside (Q3G), a glycoside of a common bioactive phytochemical quercetin, on osteogenic and adipogenic differentiation of human bone marrow-derived mesenchymal stromal cells (hBM-MSCs). hBM-MSCs were induced to differentiate into osteoblasts and adipocytes in the presence ...
1 CitationsSource